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ClpP protease activation results from the
reorganization of the electrostatic interaction
networks at the entrance pores
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Bacterial ClpP is a highly conserved, cylindrical, self-compartmentalizing serine protease
required for maintaining cellular proteostasis. Small molecule acyldepsipeptides (ADEPs) and
activators of self-compartmentalized proteases 1 (ACP1s) cause dysregulation and activation
of ClpP, leading to bacterial cell death, highlighting their potential use as novel antibiotics.
Structural changes in Neisseria meningitidis and Escherichia coli ClpP upon binding to novel
ACP1 and ADEP analogs were probed by X-ray crystallography, methyl-TROSY NMR, and
small angle X-ray scattering. ACP1 and ADEP induce distinct conformational changes in the
ClpP structure. However, reorganization of electrostatic interaction networks at the ClpP
entrance pores is necessary and sufficient for activation. Further activation is achieved by
formation of ordered N-terminal axial loops and reduction in the structural heterogeneity of
the ClpP cylinder. Activating mutations recapitulate the structural effects of small molecule
activator binding. Our data, together with previous findings, provide a structural basis for a
unified mechanism of compound-based ClpP activation.
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The caseinolytic protease P (ClpP) is a tetradecameric serineprotease comprised of two heptameric rings stacked toge-ther in a cylindrical structure. It is one of the main pro-
teolytic complexes in bacteria1. It associates with hexameric
unfoldase chaperones of the AAA+ (ATPases Associated with
diverse cellular Activities) superfamily such as ClpX and ClpA in
Escherichia coli that selectively bind, unfold, and translocate
target proteins through the axial pores of ClpP and into the
proteolytic chamber for degradation2. The proteolytic fragments
are then expelled through transient side pores or the axial
pores3–6. In the absence of the ATPases, ClpP can only degrade
unstructured or poorly folded proteins and small peptides of up
to about 30 residues7.
Structures of wild-type (WT) ClpP from different organisms as
well as ClpP with mutations, substrate mimics, and small mole-
cules have been determined3,6,8–22. Across species, ClpP has a
conserved architecture composed of an N-terminal axial loop, a
core head domain containing a Ser-His-Asp catalytic triad, and
an equatorial handle region mediating tetradecamer assembly by
interdigitation. ClpP has been crystallized in three distinct con-
formations: extended, compact, and compressed, highlighting its
plasticity23. The main difference between these states involves the
twisting and compaction of the ClpP barrel, facilitated by struc-
tural changes in the handle region found at the ring–ring
interface6,23.
Small-molecule activators of ClpP have been identified and
have shown activities against several bacterial species and cancer
cell lines, suggesting their exciting potential as antimicrobial and
antineoplastic drugs15,17,19,24–39. Brötz-Oesterhelt et al.24 dis-
covered acyldepsipeptides (ADEPs) that activate ClpP in the
absence of AAA+ chaperones, causing unspecific degradation of
cellular proteins (i.e. dysregulation of ClpP) and ultimately cell
death. The ADEPs bind with high affinity to hydrophobic pockets
on the surface of ClpP, analogous to the binding of ClpX’s IGF
loops15. While, initially, ADEPs exhibited limited antibacterial
activities24, optimization of their chemical structure has led to
analogs with improved potency against Gram-positive bacteria. In
Gram-negative species, active efflux and limited penetration of
the outer membrane caused low potencies24. Further optimiza-
tion of ADEPs by our group led to a new derivative with
improved activities against Gram-positive species, S. aureus and
E. faecalis, as well as potency against select Gram-negative spe-
cies, Neisseria meningitidis and Neisseria gonorrhoeae19. More-
over, recent efforts in our laboratory to develop other ClpP
dysregulators targeting Gram-negative bacteria have led to the
discovery of a new class of potential antibiotics named as acti-
vators of self-compartmentalizing proteases 1 (ACP1s)28. Like
ADEPs, ACP1s bind to ClpP and exhibit comparable bactericidal
properties as ADEPs but are easier to synthesize than ADEPs.
Here, we report, to the best of our knowledge, the first crystal
structure of an ACP1 activator with EcClpP, showing binding
modes that can be used to guide future drug optimization studies.
We also report the crystal structure of N. meningitidis ClpP
(NmClpP) with a novel ADEP analog, as well as of activated
NmClpP mutants that mimic the structural and kinetic properties
of ADEP- and ACP1-activated ClpP. We also characterized the
solution phase behavior of small-molecule-activated ClpP using
complementary structural techniques including methyl-TROSY
NMR and small angle X-ray scattering (SAXS). Based on these
data and extensive analysis of ClpP structures, we propose a
consensus mechanism for ClpP activation by small molecules,
wherein the reorganization of the electrostatic bonding networks
at the axial entrance pores is necessary and sufficient for activa-
tion. Further activation is achieved by reduction of the structural
flexibility of the N-terminal axial loops and of the ClpP cylinder
in general.
Results
Binding mode of ACP1 to EcClpP. To elucidate the structural
basis for ClpP activation by ACP128, structures of NmClpP and
EcClpP (Fig. 1a) in complex with ACP1 analogs were sought.
While a structure of NmClpP with bound ACP1 was not achieved
despite repeated attempts, a structure of the EcClpP+ACP1-06
complex was determined to 1.9 Å resolution (Fig. 1b, c, Table 1),
containing a tetradecamer in the asymmetric unit (Chains A-N).
Electron density for N-terminal residues that form the axial loops
of EcClpP is unclear in all but one subunit (Chain B). In pre-
viously published structures, these axial loops are highly flexible
and are usually disordered in the crystal in the absence of acti-
vators or through preclusion by crystal packing23. Unambiguous
electron density was observed for a single ACP1-06 molecule in a
pocket formed by subunits D and E, showing two different
configurations of the compound (Fig. 2a, b). Both configurations
were modeled in the electron density, in which the first config-
uration positions the trifluoromethylpyridine portion of the
compound within a hydrophobic pocket (down configuration),
while the second positions it out of the hydrophobic pocket
exposed to solvent (up configuration) (Fig. 2a). The remaining 13
hydrophobic pockets show ambiguous electron density for ACP1-
06. We modeled and refined all 14 ACP1-06 molecules in both up
and down configurations at occupancy of 0.5, resulting in
improved electron density for each ligand.
The binding modes of ACP1-06 (Fig. 2b–d) approximate those
of ADEPs observed in crystal structures of different bacterial
ClpPs (Fig. 2c–f)6,15,18,19,21,40. Note that compounds synthesized
by our group are numbered as ACP1-YY and ADEP-YY, while
compounds from studies by other groups are named as in the
respective published papers. All protein contacts with ACP1-06
are nonpolar in nature except for two notable electrostatic bonds
that occur between (1) the phenolic hydroxyl side chain of Y76
and the amide oxygen of ACP1-06, and (2) the guanidinyl side
chain of R206 (the penultimate Arg in EcClpP) and a sulfonyl
oxygen of ACP1-06 (Fig. 2b). The latter two interactions are
present in both configurations of ACP1-06. In addition, R206
(Chain E) is stabilized by ionic bonding with E65 of an adjacent
subunit (Chain D) (Fig. 3a, b).
In the down configuration, the trifluoromethylpyridine moiety
of ACP1-06 occupies a hydrophobic cavity formed by L62, T93,
and F96 (Chain D), and Y74, Y76, I104, L203, and L128 (Chain
E) (Figs. 2b and 3b). This is the same cavity occupied by the ring
of the exocyclic Phe residue of the different ADEP analogs
cocrystallized with ClpP, such as in our NmClpP+ADEP-0419
(Fig. 2e, f) or the EcClpP+ADEP1 structures40 (Fig. 2c, d). By
contrast, in the up configuration, the trifluoromethylpyridine
moiety is rotated around the C–S bond and is solvent exposed
while making van der Waals contacts with Y74, I104, F126, and
L203 (Chain E) (Figs. 2b and 3b). The gem-dimethyl moiety
stacks against the flat ring of Y74 (Chain E), while the extended
aliphatic chain terminating with an ortho-chloro-substituted
phenyl ring, sits in a nonpolar groove between two helices from
adjacent subunits (Fig. 3b). This binding cleft is formed by L62
(Chain D), F63 (Chain D), A66 (Chain D), L37 (Chain E), V42
(Chain E), and the nonpolar portion of E40 (Chain E) (Figs. 2b
and 3b).
In both ACP1-06- and ADEP1-bound structures of EcClpP,
the intrasubunit salt bridge between R36 and E40 is found, where
the nearby aliphatic tail of ADEP1 or the chloro-substituted
phenyl ring of ACP1-06 forms a hydrophobic interaction with the
side chain of E40 (Fig. 3b, c). The two activators are further
stabilized in the hydrophobic site by two distinct hydrogen bond
patterns. While ACP1-06 is secured through a solvent-exposed
ionic interaction between its sulfonyl group and the C-terminal
R206 residue (Fig. 3b), ADEP1 is held in place by two hydrogen
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bonds with the hydroxyl group of Y76 secluded within the
hydrophobic site (Fig. 3c). A solvent-mediated hydrogen bond
between E65 and the carbonyl group of the N-acyl Phe side chain
of ADEP1 further strengthens its interaction with EcClpP
(Fig. 3c). This extra hydrogen bond, as well as the larger size of
the cyclic depsipeptide ring, which has more surface area with
which to form van der Waals interactions compared to the
smaller trifluoromethylpyridine group of ACP1, may account for
the generally tighter binding observed for ADEPs than ACP1s28.
In the EcClpP+ACP1-06 structure, we found an unexplained
electron density in all 14 subunits extending from the
nucleophilic residue S111 of the catalytic triad, suggesting a
covalent modification (Supplementary Fig. 1a, b). The density
extends at approximately right angles in opposite directions away
from the S111 side chains. Despite extensive efforts, it could not
convincingly be fitted with peptides, acylketone products or
various known serine protease inhibitor molecules.
Binding mode of ADEP to NmClpP. NmClpP has a shorter pro-
sequence at the N-terminus, while having four extra residues at
the C-terminus compared to EcClpP (Fig. 1a). Although NmClpP
was expressed as a full-length protein carrying an N-terminal
His6-tag, we repeatedly observed lack of binding to the Ni-
nitrilotriacetic acid resin. N-terminal sequencing of the purified
protein revealed that the mature NmClpP starts at residue Y6
(Fig. 1a), indicating autoproteolysis to release its N-terminal pro-
sequence (1MSFDN5).
Previously, we had determined the structure of NmClpP with
ADEP-0419. In this study, we determined the structure of apo-
NmClpP to 2.0 Å and NmClpP with bound ADEP-14 to 2.7 Å
(Fig. 1b, c, Supplementary Fig. 1c, Table 1). The structure of apo-
NmClpP contains a tetradecamer in the asymmetric unit and
shows no clear density for any of the 14 N-terminal axial loops.
Weak electron density is observed for the loops formed by
residues G133-G137 in strand β8 of the handle region (Fig. 1a).
EcClpP (1YG6)
*EcClpP + ACP1-06 (6NB1)
EcClpP (1YG6)
EcClpP + ADEP1 (3MT6)
*NmClpP (6NAQ)
*NmClpP + ADEP-14 (6NAH)
*NmClpP (6NAQ) 



































































































































Fig. 1 Sequence and structure of ClpP from N. meningitidis and E. coli. a Sequence alignment of ClpP from N. meningitidis (NmClpP) and E. coli (EcClpP). The
pro-sequence is in the gray rectangle. Residues of the Ser-His-Asp catalytic triad are in the blue rectangles and marked with asterisks. Residues mutated in
NmClpP (E31, E58) and EcClpP (E40, E67, Y76) as described in Fig. 4a, b are highlighted in green rectangles. Residues that participate in electrostatic
interactions near the axial pore are enclosed in purple rectangles (E13, D23, S26, R27, and S57 in NmClpP). Residue S57 in NmClpP corresponds to A66 in
EcClpP. Residues T10 and I144 of NmClpP mutated in spin-labeling NMR studies are enclosed in black squares. Secondary structures of NmClpP are shown
on top of the sequence. b Chemical structures of the different compounds used in this work. c Crystal structures of ClpP showing global conformational
changes upon ACP1 or ADEP binding. The structures determined in this study (indicated by asterisk and with labels bolded) of EcClpP with ACP1-06
(6NB1), apo-NmClpP (6NAQ), and NmClpP with ADEP-14 (6NAH)) are shown together with the structures of apo-EcClpP (1YG610), EcClpP with ADEP1
(3MT640), and NmClpP with ADEP-04 (5DKP; also solved by our group19) for comparison. Proteins are in cartoon representation, while ACP1 and ADEP
compounds are in stick models. Apo structures of EcClpP and NmClpP are colored gray, while activator-bound structures are colored green (EcClpP) and
purple (NmClpP+ADEP-14/ADEP-04). Axial loop ordering is observed in ADEP1- or ADEP-04-bound structures of EcClpP and NmClpP, respectively, while
this is not observed in the ADEP-14 bound structure of NmClpP due to crystal packing (Supplementary Fig. 1d)
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The asymmetric unit for the NmClpP+ADEP-14 crystal contains
two tetradecamers (Supplementary Fig. 1d). No electron density
was observed for residues 1–22 of all 28 subunits due to crystal
packing (Fig. 1c, Supplementary Fig. 1d). In addition, the β8-
strand (residues 130–137; Fig. 1a) is only partially visible in all
subunits. ADEP-14 is bound to NmClpP in a similar configura-
tion as ADEP-04 (Figs. 2e, f and 3e, f). Briefly, the difluorophenyl
moiety of ADEP-14 occupies a hydrophobic pocket formed by
Y67, L95, L97, and L119 of one subunit, and V49, L53, T84, and
F87 of an adjacent subunit (Fig. 3e). The six-membered ring of
the pipecolic acid moiety is solvent exposed and is stabilized by
the phenyl ring of F117 and the hydrophobic side chains of L97,
L119, and L196 (Fig. 3e). The additional methyl substitution on
the allo-threonine residue of the depsipeptide ring (Fig. 1b) is
solvent exposed. Like ADEP-04, ADEP-14 is secured in the highly
complementary hydrophobic pocket by two hydrogen bonding
interactions between the phenolic hydroxyl group of Y67, the
amino group of the difluorophenylalanine residue, and the
alanine carbonyl group in the depsipeptide ring, and a solvent-
mediated hydrogen bond with E56 (Fig. 3e, f). The octadienoic
acid side chain of ADEP-14 is located in the narrow hydrophobic
channel formed by L53, F54, and S57 of one subunit, and R27,
L28, E31, I33, F35, and Y67 of the neighboring subunit (Fig. 3e).
ACP1- and ADEP-binding result in distinct allosteric effects
on the ClpP barrel. Using structures of apo- and compound-
bound forms of EcClpP and NmClpP (Fig. 1c), we probed the
allosteric effects that occur upon activator binding. As shown in
Supplementary Fig. 2, activator binding acts as a wedge causing
the lateral displacement of two adjacent subunits. The extent of
global conformational change caused by ACP1-06 binding (rmsd
= 0.84 Å relative to apo-EcClpP) is similar to that for ADEP-04
(rmsd= 0.73 Å relative to apo-NmClpP), but less than that for
ADEP-14 (rmsd= 2.47 Å relative to apo-NmClpP). Interestingly,
the direction of displacement is different between the two classes
of activators (Supplementary Fig. 2 and Supplementary Movies 1–
4). Between the two ADEPs, ADEP-14 causes a greater overall
structural perturbation to the NmClpP cylinder (compare Sup-
plementary Movies 3 vs. 4). ADEP-binding results in an expan-
sion of the apical surface of NmClpP accompanied by
constriction at the equatorial region. The pivot for this motion is
in the handle region composed of helix αE and strand β8. This
phenomenon is observed in all ADEP-bound ClpP structures
known to date, with varying degrees of compaction of the ClpP
cylinder15,18,19,23,40. By contrast, ACP1-06 binding to EcClpP
causes an inward movement of all subunits resulting in tightening
of the ClpP cylinder (Supplementary Movie 1). Thus, the struc-
tures show that ACP1s and ADEPs activate ClpP by inducing
distinct allosteric effects.
In the activator-bound EcClpP and NmClpP structures, the
ring–ring interface electrostatic bonds that stabilize the tetra-
decamer remain conserved despite the conformational changes
(Supplementary Fig. 3). Moreover, notwithstanding the global
structural change upon activator binding, the Ser-His-Asp
catalytic triads of EcClpP and NmClpP maintain catalytically
competent geometries as only minor Cα backbone shifts occur
near the active site (Supplementary Fig. 1a–c). Analysis of all
existing ACP1- and ADEP-bound structures of ClpP shows that
compound binding also results in the contraction of the
equatorial region (Supplementary Fig. 4).
We quantified the compaction of the ClpP cylinder upon ACP1
or ADEP binding by measuring the volumes of the respective
catalytic chambers (Supplementary Fig. 4). ACP1-06 binding
causes a ~5% decrease in the catalytic chamber volume relative to
apo-EcClpP. ADEP1-binding to EcClpP results in a similar
decrease in catalytic chamber volume. This is also observed for
other activator-bound ClpP structures such as ADEP-14-bound
NmClpP, ADEP-bound BsClpP, and the ADEP-bound
MtClpP1P2 heterooligomeric complex (Supplementary Fig. 4).
ClpP activation results in the reorganization of the electro-
static bonding network at the axial pores. In the structure
of apo-NmClpP, two electrostatic bonds near the axial pore sta-
bilize the interface of any two adjacent subunits (Fig. 3d,
Table 1 Data collection and refinement statistics




C 2 P 21 P 21 P 21 P 1
a, b, c (Å) 191.0, 101.1 155.2 98.6, 128.0,120.2 117.2, 196.0, 97.4 98.1, 119.4, 127.6 98.7,119.8, 127.9
α, β, γ (°) 90.0, 98.3, 90.0 90.0, 90.2, 90.0 90.0, 97.4. 90.0 90.00, 89.98, 90.00 90.02, 89.99, 90.02
Resolution (Å) 48.0–1.9 (2.00–1.90) 51.4–2.0 (2.15–2.02) 50.0–2.7 (2.75–2.70) 50.0–2.4 (2.44–2.40) 50.0–2.2 (2.24–2.20)
CC1/2 (%) 99.9 (70.2) 99.6 (94.9) 99.8 (55.9) 99.9 (66.0) 99.7 (76.9)
Completeness (%) 98.3 (94.3) 98.2 (96.8) 98.7 (97.6) 100.0 (99.7) 95.4 (92.7)
Redundancy 3.9 (3.4) 3.9 (3.8) 3.8 (3.8) 3.7 (3.5) 1.9 (1.8)
Refinement
Resolution (Å) 48.0–1.9 51.4–2.0 49.6–2.7 42.0–2.4 46.1–2.2
No. reflections 223700 189962 168438 114987 283402
Rwork/Rfree 20.9/24.4 20.7/24.6 19.6/25.1 19.3/25.2 21.5/24.3
No. atoms
Protein 20133 20048 37399 19461 38118
Ligand 812 0 1973 0 0
Water 923 633 691 897 1862
B-factors (Å)2
Protein 30.0 25.0 42.0 36.0 39.0
Ligand 61.2 N/A 44.8 N/A N/A
Water 30.1 23.7 42.5 36.6 31.5
r.m.s. deviations
Bond lengths (Å) 0.010 0.008 0.009 0.009 0.010
Bond angles (°) 1.24 1.16 1.37 1.16 1.10
Values in parentheses are for highest-resolution shell
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Supplementary Fig. 5). First, the negatively charged E58 carbox-
ylate group of one subunit forms an ion pair with the positively
charged R27 guanidinium group of the adjacent subunit. Second,
the S57 hydroxyl and E31 carboxylate groups of two adjacent
subunits form a hydrogen bond. Upon ADEP binding, these two
noncovalent bonds break, while the ionic bond between R27 and
E31 of the same subunit is shortened, i.e. strengthened (Fig. 3e, f).
In apo-EcClpP, only one ionic bond between E67 and R36 links
two adjacent subunits, since the equivalent residue to S57 of
NmClpP is an alanine in EcClpP and is thus unable to form a
hydrogen bond with E40 (Fig. 3a). As in NmClpP, binding of
ACP1 or ADEP1 to EcClpP eliminates the intersubunit E67-R36
ionic bond and gives rise to a stronger intrasubunit ionic bond
between R36 and E40 (Fig. 3b, c, Supplementary Fig. 5).
To further verify these observations, we designed NmClpP and





Fig. 2 Binding modes of ACP1 and ADEP in the hydrophobic pocket of ClpP. a Omit map contoured at 1 σ showing the up and down configurations of ACP1-
06. b Two-dimensional plots showing EcClpP residues that interact with ACP1-06 via hydrogen bonding and hydrophobic interactions. c, d Surface
representations of the hydrophobic pocket of EcClpP showing the binding modes of ACP1-06 and ADEP1. The protein surface is colored according to its
electrostatic potential with positive in blue and negative in red. ACP1-06 is shown in magenta and pink and ADEP1 in cyan. In (d), a cut view of the binding
pocket is displayed highlighting the hydrophobic pocket, which accommodates the phenylalanine moiety of ADEP1 and the trifluoromethylpyridine group of
ACP1-06 in the down configuration. e, f Surface representations of the NmClpP hydrophobic pocket with bound ADEP-04 and ADEP-14
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electrostatic bonds. As shown in Fig. 4a, while WT NmClpP was
unable to degrade the protein casein, the NmClpP E58A mutant
was found to degrade casein at a higher rate than the E31A
mutant. Importantly, the double mutant E31A+ E58A had an
even higher activity than the single mutants. The extent of
activation of the double mutant NmClpP is similar to that
observed in the presence of 1 µM ADEPs or 10 µM ACP1s
(Fig. 4a). Similar behavior was observed for EcClpP with similar
mutations (E40A and E67A; Fig. 4b). The respective EcClpP
double mutant is not soluble and could not be tested.
Subsequently, we determined X-ray structures of NmClpP
E58A and NmClpP E31A+ E58A mutants (Table 1). The
catalytic sites in both mutants are not perturbed (Supplementary
Fig. 1e). In the NmClpP E58A single mutant, the mutation
abolishes the intersubunit E58–R27 ionic bond and gives rise to a
stronger intrasubunit R27–E31 interaction, while the hydrogen
bond between S57 and E31 remains (Fig. 4c). A similar “wedge
effect” is thus observed in the structure, as shown by the subtle
global conformational change in the NmClpP mutant’s Cα
backbone (rmsd= 0.33 Å relative to WT NmClpP) (Supplemen-
tary Movie 5). Mutation of both E31 and E58 to alanine to
generate the double mutant NmClpP E31A+ E58A (rmsd= 0.29
Å relative to WT NmClpP) abolishes the two stabilizing
intersubunit electrostatic interactions, as well as, the intrasubunit
R27–E31 ionic bond present in the NmClpP E58A single mutant
(Fig. 4d and Supplementary Movie 6) and in ADEP-bound
NmClpP (Fig. 3e, f). Thus, the NmClpP E31A+ E58A double
mutant is unlike ADEP-bound NmClpP with the eliminated
intrasubunit ionic bond but is nonetheless an activated protein
with intrinsic proteolytic activity comparable to that of small-
molecule-activated ClpP (Fig. 4a). Like ADEP-bound NmClpP,
both NmClpP single and double mutants have reduced catalytic
chamber volumes due to ClpP barrel compaction (Supplementary
Fig. 4).
Such reorganization of the bonding network is observed for all
activated ClpP structures available in the PDB, whether in the
presence of small-molecule activators or due to specific mutations
(Supplementary Fig. 6). For example, small-molecule activator
binding to B. subtilis ClpP (BsClpP), S. aureus ClpP (SaClpP), M.
tuberculosis ClpP (MtClpP), and Homo sapiens ClpP (HsClpP)
abolishes one or two intersubunit electrostatic bonds near the
axial pore, and gives rise to a stronger, intrasubunit ionic
interaction (Supplementary Fig. 6a–e, g–l)6,15,18,21,39. In
MtClpP2, the intersubunit ionic bond equivalent to the
F126(E)

































































































































EcClpP + ADEP1 (3MT6)
c 7.0 Å
2.8 Å
Fig. 3 Close up view of the activator binding site in ClpP. a–c The interface between two subunits of apo-EcClpP, EcClpP+ACP1-06, and EcClpP+ADEP1.
d–f The interface between two subunits of apo-NmClpP, NmClpP+ADEP-14, and NmClpP+ADEP-04. In all the panels, distances between residues
discussed in the text are indicated by dashed lines. If the distance is ≤4.3Å, then the dashed line is in black, otherwise the dashed line is in red. 4.3Å is the
distance observed in apo-EcClpP (1YG6) between the side chains of E67(D) and R36(E) (Fig. 3a)
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E58–R27 interaction in NmClpP does not exist18. The equivalent
residue for E58 of NmClpP is L66 in MtClpP2 and is unable to
participate in an ionic interaction with K35 of MtClpP2
(equivalent to R27 of NmClpP). Instead, an intersubunit
hydrogen bond between S65 and E39 stabilizes the interface
(Supplementary Fig. 6g, h). ADEP binding to MtClpP2 breaks the
S65–E39 hydrogen bond and strengthens the intrasubunit ionic
bond between K35 and E3918.
Interestingly, even the activated SaClpP Y63A variant41, with
the activating mutation found in the center of the hydrophobic
site, and, therefore, not equivalent to the activating mutations of
NmClpP presented here, supports our proposed model of the
reorganization of the hydrogen bonding network around the axial
pore upon ClpP activation (Supplementary Fig. 6f). In the
structure of the SaClpP Y63A mutant, the distance between the
intersubunit ion pair (Q54–R23) is increased, while the
intrasubunit salt bridge (R23–D27) is strengthened (Supplemen-
tary Fig. 6d, f). We also generated the equivalent Y63A mutation
in both EcClpP and NmClpP. The NmClpP Y67A mutant was
insoluble, while the EcClpP Y76A had an activity slightly higher
than the E40A mutant, but lower than that of the E67A mutant
(Fig. 4b).
ClpP activation results in reduction in structural heterogeneity
of the N-terminal axial loops. As discussed above, in the ordered
axial loop of the NmClpP+ADEP-04 complex forming the β1–β2
hairpin turn, ADEP binding releases R27 from an intersubunit
ionic bond with E58 and strengthens the intrasubunit ionic bond
with E31 of helix αA (Fig. 5a). Consequently, R27 forms an ionic
bond with D23 of strand β1 of the axial loop. This stabilizing
interaction is observed in all activator-bound structures of ClpP
where the axial loops are ordered (Fig. 5a–e).
For the EcClpP+ACP1-06 structure, the axial loops (residues
14-31) are partially ordered in the crystal with only 1 out of 14
axial loops forming the β1–β2 hairpin turn (Fig. 1c—complete
ordering seems to be partly prevented by crystal packing effects).
In the ordered axial loop of subunit A, release of R36 from the
intersubunit ionic bond with E67 allows it to form a stronger
intrasubunit ionic bond with E40 of helix αA (Fig. 5f). However,
there is no stabilizing ionic interaction between E22 of strand β1
and R36 of helix αA, likely due to partial ordering (Fig. 5f). An
additional hydrogen bond between D32 of strand β2 and S21 of
helix αA anchors the axial loop to the EcClpP core domain
(Fig. 5f). Similarly, the axial loops in the Enterococcus faecium
ClpP (EfClpP)-ADEP4 structure are only partially ordered21. The
conserved hydrogen bond between the Arg residue of helix αA
and a negatively charged residue of strand β1 is not seen in the
partially ordered EfClpP axial loops, although EfClpP has
potential hydrogen bond forming residues on strand β1 (T6),
and on the loop connecting strands β1 and β2 (E9, Q10, S11, S12,
E15) (Fig. 5g).
In addition to conserved electrostatic interactions, extensive































































































Fig. 4 Activating mutations in NmClpP and EcClpP. a, b Comparison of the proteolytic activities of mutant EcClpP and NmClpP with compound-activated
ClpP using casein-FITC as model substrate. Compound structures are shown in Fig. 1b. All experiments were carried out 3 times. Source data are available
in Supplementary Data 1. c The interface between two subunits in NmClpP E58A mutant. d The interface between two subunits in NmClpP E31A+
E58A mutant
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axial loops. In EcClpP+ACP1-06, nonpolar N-terminal residues
of strand β1 and the preceding structured coil participate in
hydrophobic interactions with nonpolar residues of helix αA of
the same subunit, and on the hydrophobic faces of helices αA′
and αB′ of a neighboring subunit (Supplementary Fig. 7a). The
nonpolar residues on helices αA, αB′, and β3′ constitute a
continuous hydrophobic patch on the circumference of the axial
pore (Supplementary Fig. 7b)15.
To get a clearer picture of the conformational heterogeneity of
the ClpP axial loops, methyl-TROSY NMR experiments were
then carried out. Initially, a single cysteine mutation was
introduced in the axial loops of NmClpP(T10C). Uniformly
deuterated protein was produced and subsequently reacted with
13C-methyl-methanethiosulfonate (MMTS). This results in the
attachment of a single NMR visible 13CH3–S group to the
cysteine side chain, leading to formation of an S-methylthio-
cysteine (MTC) residue42. This method provides a facile way of
monitoring the structure and dynamics of large complexes in
solution. Monitoring the NMR correlations of the attached spin
probe in free, activator-bound or mutated forms of the enzyme
provides a readout of the solution conformation of the
axial pores.
Initially, control experiments were performed to ensure that
the introduction of the T10MTC moiety does not perturb the
structure of NmClpP. Briefly, 1H–13C heteronuclear multiple
quantum coherence (HMQC) correlations of WT and T10MTC
NmClpP labeled 13CH3 at the side chain of ILVM residues in an
otherwise fully deuterated background were compared and found
to be virtually identical. Subsequently, 1H–13C HMQC correla-
tions of NmClpP T10MTC were obtained in different states
(Fig. 6a). The apo-form (blue contours) has a large number of
correlations, indicating structurally heterogeneous axial loops.
Addition of two-fold molar excess of ADEP-28 (activity given in
Fig. 4a) over monomeric ClpP significantly reduced the number
of correlations (red contours), indicative of rigidification or
structural ordering. By contrast, ACP1-17 binding (two-fold
EcClpP + ADEP1 (3MT6) 
SaClpP Y73A (5C90) MtClpP2 + ADEP-2B5Me (4U0G)























































































































Fig. 5 Ordering of the N-terminal axial loops in activated ClpP. a–g The relevant interactions promoting axial loop ordering in ClpP-activating compound
complexes are highlighted
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Fig. 6 Analysis of NmClpP dynamics by NMR and of the protease solution structure by SAXS. a 1H–13C HMQC spectra of NmClpP labeled with MMTS to
produce single 13CH3 probes on axial loop (positions 10) and handle helix (position 144). Spectra were recorded in apo-, ADEP-28- and ACP1-17-bound
forms, as well as, for constructs bearing activating mutations. NmClpP protomer concentration ranged between 200–250 μM. Compounds were at two-
fold molar excess over protomer concentration. b Scattering curves of NmClpP in the absence (black) and presence (blue) of ADEP-04. Symbols represent
experimental data; solid lines represent the fitting of GNOM curves. The values for the NmClpP+ADEP-04 curve were divided by 10 for comparison
purposes. c Pair distance distribution functions, p(r), of NmClpP determined by the GNOM software. Apo NmClpP is displayed in black, whereas NmClpP-
ADEP-04 is shown in blue. d, e Most probable dummy atom models (DAMs) for apo-NmClpP and NmClpP+ADEP-04 are shown as gray dots. The fitting
of DAM scattering profiles to experimental data are shown in Supplementary Fig. 9b. Apo-NmClpP (black) and NmClpP+ADEP-04 (blue) crystal
structures were superimposed onto the DAMs using the SUPCOMB program65. DAMs averaged axial height based on ten independent DAMMIN runs are
displayed next to each model. The scale bar is shown at the bottom. f, g DAMs probability maps (gray dots) derived from the average of all models
generated by the DAMMIN program62 (mean normalized spatial discrepancy, NSD, of 0.745 ± 0.033 for apo-NmClpP and 0.708 ± 0.027 for ADEP-04-
bound NmClpP; values close to 0 refer to ideally superimposed structures and values higher than 1 to significantly different ones) and regions of the highest
DAs occupancy are shown for apo-NmClpP (black) and ADEP-04-bound NmClpP (blue) in two different views. The heights for both averaged probability
maps and highest DA occupancy maps are given. The circumferences of the axial pores for the highest DA occupancy maps are also given. 3D structures
and DAMs were rendered using the UCSF Chimera software (https://www.cgl.ucsf.edu/chimera/)
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molar excess over monomeric ClpP; activity given in Fig. 4a)
results in undetectable changes in the observed correlations
(green contours), implying that the axial loops are unaffected.
This approach was also exploited to monitor the effect of
activating mutations (Fig. 4a, b) on the axial loops. In these
experiments, the activating mutations were introduced in the
background of the T10C (labeling) mutation. As shown in Fig. 6a,
correlations of the NmClpP T10MTC/E31A mutant (red
contours) is slightly less heterogeneous than the pseudo WT
form, while those of the NmClpP T10MTC/E58A mutant (orange
contours) are virtually unchanged. The simultaneous presence of
both activating mutations (NmClpP T10MTC/E31A+ E58A) has
a much more dramatic effect than single mutations and removes
a large number of correlations corresponding to the axial loops
(black contours). This is consistent with the observation that the
double mutant is more active than the single mutants (Fig. 4a).
ClpP activation results in reduction in conformational het-
erogeneity of the handle region. The same NMR-based approach
was used to probe the effect of activator binding and mutations
on the handle region. An I144MTC (helix αE) mutant of NmClpP
was prepared and studied by NMR in apo-, ADEP-28-, and
ACP1-17-bound forms. The apo-form (blue contours, Fig. 6a)
exhibits a pair of peaks, indicating that the handle region is
associated with a pair of coexisting conformations, as seen in our
previous work on EcClpP4. Interestingly, addition of ACP1 and
ADEP leads to the disappearance of one of the peaks. Given that
the activator binding site is distal to the NMR spin probe, it
appears that ACP1 or ADEP binding allosterically selects for one
of the conformations in the handle region. Alternatively, activa-
tors might be able to bind both forms but induce a change to a
single state.
Magnetization exchange experiments with mixing delay periods
of 100, 200, 300, 400, 500, and 600ms at 40 °C were unable to
detect any interconversion between the conformers observed for
the handle region for WT NmClpP. This indicates that the
exchange process is too slow for characterization by NMR.
SAXS demonstrates activator-induced ClpP conformational
changes in solution. To further probe the oligomeric state and
structural changes upon compound binding, apo-NmClpP and
NmClpP+ADEP-04 samples were characterized by SAXS
(Fig. 6b–g and Supplementary Fig. 8). Final merged curves are
shown in Fig. 6b, and the SAXS profiles obtained resembled those
of hollow structures43. No significant changes were found in
terms of overall folding (Supplementary Fig. 8), radius of gyration
(Rg) and oligomeric state when ADEP-04 was added to NmClpP
(Supplementary Fig. 8c). In order to further analyze the NmClpP
SAXS profiles and generate solution ab initio structures, the
GNOM program was used to construct pair distance distribution
functions, p(r). Apo-NmClpP p(r) revealed a subtle right-shift
and larger maximum dimension (Dmax) in comparison to ADEP-
04-bound NmClpP (Fig. 6c and Supplementary Fig. 8c). Subse-
quently, dummy atom models (DAMs) were generated using
SAXS data to visually analyze NmClpP solution structures
(Fig. 6d–g). Ten models were generated for apo-NmClpP and
ADEP-04-bound NmClpP, and the most probable ones were
chosen. These models showed that, overall, the two NmClpP
solution structures are similar (hollow cylinders). However, when
superimposed with the corresponding crystal structures, differ-
ences that agree with the high-resolution structures were easily
observed (Fig. 6d, e). A measure of the axial heights of all ten
DAMs for apo- and ADEP-04-bound NmClpP resulted in values
of 93.0 ± 5.4 Å for the apo-form and 103.5 ± 6.1 Å for the ADEP-
04-bound form. To further corroborate this observation, averaged
DAMs probability maps and highest DAs occupancy maps
(Fig. 6f, g) were analyzed. The axial heights displayed an increase
of about 10 Å for ADEP-04-bound NmClpP in comparison with
apo-NmClpP. Moreover, ADEP-04-bound NmClpP displayed a
larger axial pore circumference than apo-NmClpP (Fig. 6f, g).
Thus, despite the low resolution of the SAXS technique, the
results suggest that ADEP-04 binding to NmClpP does not affect
the oligomeric state of NmClpP but causes an expansion of the
axial pores and increased occupancy at the top and bottom parts
of the NmClpP+ADEP-04 DAM (Fig. 6e, g) compared to apo-
NmClpP. This likely reflects the conformational changes leading
to the decreased heterogeneity of the structure of the N-terminal
axial loops of NmClpP observed by X-ray and NMR.
Discussion
The high-resolution crystal structures of ClpP in complex with
ACP1 and ADEP activators presented here show that, while the
two classes of compounds share a common binding site, their
mechanisms of activation are dissimilar in both magnitude and
detail (Supplementary Fig. 2 and Supplementary Movies 1–4).
ADEP binding induces a more pronounced conformational
change in ClpP, with the magnitude of axial pore expansion and
equatorial constriction being greater than those caused by ACP1
binding. In ADEP-bound complexes of NmClpP, the head
domain moves away from the central 7-fold axis, while the handle
region moves toward the axis as the barrel constricts at the
equator. By contrast, ACP1 binding to EcClpP tightens the pro-
tease barrel by drawing all 14 subunits inwards towards the long
axis. These conformational changes in ACP1- and ADEP-bound
structures result in reduced catalytic chamber volumes (Supple-
mentary Fig. 4) and wider axial pores that can facilitate substrate
entry and increase proteolytic activity. Importantly, we demon-
strated that, specific mutations which abolish electrostatic inter-
actions lining the axial pore (Fig. 4a, b), mimic the wedge-like
action of these small-molecule activators.
Our analysis also revealed the molecular details that link axial
loop ordering to catalytic activation (Fig. 7a). In activated ClpP,
elimination of an intersubunit ion pair involving a conserved
Arg/Lys residue on helix αA and Glu/Gln residue on helix αB'
frees the Arg/Lys residue to form an intrasubunit salt bridge with
a conserved Glu/Asp residue on strand β1 of the axial loop, while
the interaction of Arg/Lys with a conserved Glu/Asp residue on
the same helix αA is strengthened (Fig. 7a). In addition, a con-
served hydrogen bond between an Asp/Asn residue on strand β2
and a Ser/Asn residue on helix αA further fastens the N-terminal
β-hairpin structure to the ClpP core (Fig. 7a). In some ClpPs, a
second intersubunit interaction between a Ser on αB′ and the
Glu/Asp on αA is present and is broken or weakened upon
activator binding (Fig. 7a). Conserved extensive sets of hydro-
phobic interactions between nonpolar residues of the ordered N-
terminus preceding strand β1, and those of helices αA, αB′, and
β3′ complete the stabilizing contacts of the ordered axial loops
with the ClpP cylinder (Supplementary Fig. 7a). The net effect of
axial loop ordering is the retraction of disordered N-terminal
sequences that plug the axial pore, forming a collar that delimits
the axial openings of ClpP. Many of the residues involved in these
interactions are conserved in ClpP from different species (Sup-
plementary Fig. 9). Further activation can then be achieved by
reducing structural heterogeneity around the axial pores and the
equatorial region, leading to a fully active conformer of ClpP
(Fig. 7b). Thus, the unified mechanism we propose (Fig. 7b)
articulates both the minimum requirement for activation (elec-
trostatic network reorganization around the axial pores) and the
existence of an activation gradient for ClpP that encompasses
different conformational states.
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Fig. 7 Mechanism of ClpP activation by small molecules. a Schematic diagram showing mechanism of axial loop ordering. Small-molecule activator binding
to hydrophobic binding pockets acts as a wedge between adjacent subunits, abolishing one or two intersubunit electrostatic bonds near the axial pore
typically formed between two neighboring subunits (Glu/Gln in αB′ and Arg/Lys in αA; Ser in αB′ and Glu/Asp in αA). This gives rise to a stronger
intrasubunit ionic bond between the Arg/Lys and a Glu/Asp in αA, as well as, to interactions between the Arg/Lys in αA and Glu/Asp in β1 and Ser/Asn in
αA and Asp/Asn in β2. The latter interactions promote axial loop ordering. b Proposed activation spectrum for ClpP, beginning in the apo state. In this state
(left structures), axial loops are disordered (broken pink loops), and there is significant heterogeneity in the equatorial region (various conformations of
secondary structures with yellow coloring indicates structural heterogeneity). Axial loop disorder plugs the axial pores. Weaker activators such as some
ACP1s (green sticks in middle structures) decrease axial loop structural heterogeneity, widen the axial pores, and rigidify the ClpP structure to a significant
extent (decreased yellow coloring at the equatorial region), but to a lesser extent than that by stronger activators such as ADEPs (green sticks in rightmost
structures). In the fully activated state, axial loops are ordered (solid pink surface), and ClpP structural heterogeneity is further reduced (solid surface for
the ClpP barrel). Mutations that disrupt bonding networks near the axial pores result in ClpP species whose activities lie somewhere in the activation
spectrum and possess structural features in common with small-molecule-activated ClpP, including less conformational heterogeneity in axial loops and
handle regions relative to the apo state. Structures used to depict states in the activation spectrum have the following PDB accession codes: 1TYF (EcClpP)
for non-activated apo state, 6NB1 for intermediate state (EcClpP+ACP1-06), and 3MT6 (EcClpP+ADEP1) for fully activated state. Ordered axial loops
from 3MT6 were superimposed and then shown as broken lines with transparent surface to depict heterogeneity in the apo state, or as partially ordered
structures with slightly darker surfaces in the intermediate state
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The previously accepted mechanism for ClpP activation
emphasizes three structural features induced by activator binding:
(1) formation of ordered axial loops (β-hairpin turns) from dis-
ordered N-terminal loop sequences, whose first few residues are
hydrophobic and plug the axial pore in the apo state (dissolution
of hydrophobic plug)31; (2) anchoring of the β-hairpin turns via
their hydrophobic N-termini to the hydrophobic patch lining the
circumference of the axial pores with the alkyl/aryl groups of the
activators serving as hydrophobic nucleation sites to trigger the
retraction of the β-hairpin turns away from the center of barrel
(hydrophobic pull)31; and (3) rigidification of the equatorial
handle region, thereby constraining ClpP to its active form
(conformational selection)31,34.
Our observations on ACP1-ClpP complexes indicate that
contrary to feature 1 of the current mechanism, complete dis-
solution of the hydrophobic plug by formation of all 14 axial
loops is not required for activation. The structure of EcClpP-
ACP1-06 complex (Fig. 5f) is evidence to this claim, in con-
junction with the result of our NMR studies on NmClpP with
ACP1-17. Rather, we find that mere reorganization of electro-
static interactions near the axial pore, is the critical event pre-
ceding hydrophobic plug dissolution (feature 1) and the
hydrophobic pull (feature 2) and is necessary and sufficient for
ClpP activation (Figs. 3 and 7). This new insight thus resolves the
obfuscation of the true significance of axial loop ordering in the
context of activation, imposed by invisible or only partially
ordered axial loops often seen in structures of activated ClpP
complexes15,21,39,44.
Methods
Plasmids and subcloning. The N. meningitidis clpP gene was PCR amplified from
N. meningitidis MC58 genomic DNA with either Pfu (Fermentas) or Phusion
(Thermo Fisher) DNA Polymerase. The PCR products were inserted into p11, a
pET vector (Novagen) modified to add an N-terminal 6x-His tag followed by a
tobacco etch virus (TEV) protease recognition sequence. The plasmid places the
gene under the control of isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible
promoter. The construct was verified by Sanger sequencing. Mutants of NmClpP
were constructed using designed primers and standard mutagenic PCR reactions.
The plasmid pET9a EcClpP used for protein overexpression was a generous gift
from Dr. John Flanagan (Pennsylvania State University College of Medicine, USA).
Protein expression and purification for biochemical assays and X-ray struc-
ture determination. ClpP constructs were expressed in the BL21(DE3)1146D
strain, which lacks the gene for endogenous EcClpP. EcClpP and NmClpP were
expressed and purified generally as previously described for EcClpP45. Briefly, an
overnight culture of BL21(DE3)1146D cells transformed with the respective ClpP
plasmid was inoculated at a 1:100 dilution into LB media supplemented with
ampicillin. The culture was agitated for 3 h at 37 °C to an OD600 of 0.5 to 0.7. IPTG
was added to a final concentration of 1 mM, and the culture was incubated for
another 4 h. Cells were harvested by centrifugation and resuspended in buffer A
(50 mM TrisHCl, pH 7.5, 150 mM KCl, 10% glycerol, and 1 mM DTT), and lysed
using a French Press. The protein was then fractionated using ammonium sulfate
precipitation, resuspended in buffer A and, subsequently, purified on a Q-
Sepharose column followed by an SP Sepharose column or a Superdex 200 column
(all columns from GE Healthcare Life Sciences). N-terminal sequencing of
NmClpP was carried out by sequential Edman reactions at the SPARC BioCentre at
The Hospital for Sick Children, Toronto. Protein concentrations were determined
by absorbance at 280 nm with extinction coefficients calculated using ProtParam
(http://ca.expasy.org/tools/protparam.html) or by Bradford assay (Bio-Rad
Laboratories).
ClpP activity assays. The activity of compound-activated ClpP was determined by
fluorescence using a FITC-labeled casein substrate (Millipore-Sigma, product
#C3777). Each 200 μL reaction contained 3.6 μM ClpP, 1% DMSO, 10 μM ACP1 or
1 μM ADEP, in 25 mM TrisHCl, pH 7.5, and 100 mM KCl. Reaction mixtures were
pre-incubated for 10 min at 37 °C in a black 96-well plate before casein-FITC was
added to a final concentration of 4.5 μM. Control reactions contained 1% DMSO,
but no compound. Reactions were monitored by fluorescence (490 nm excitation,
525 nm emission) on an EnSpire plate reader (Perkin Elmer) equipped with a
fluorescence module for 1 h, with a reading every 10 s. Initial rates were calculated
using the initial linear slope of the degradation curve, typically within the first 10
min. All rates were normalized to the degradation rate of the EcClpP E40A mutant
without compound.
Statistics and reproducibility. All enzymatic assays of ClpP were done at least in
triplicate.
X-ray crystal structure determination and refinement. E. coli ClpP was dis-
solved at 10 mg/mL in 10 mM HEPES, pH 7.5, and 200 mM NaCl containing 5 mM
ACP1-06 (dissolved in DMSO). The solution was mixed with and incubated above
a well solution containing 51-63% 2-methyl-2,4-pentanediol (MPD) and 0.1 M
sodium acetate, pH 5.0 at room temperature (RT). Diffraction data from an
EcClpP+ACP1-06 crystal, flash-frozen in a boiling nitrogen stream, were collected
with 0.97949 Å wavelength X-rays at the Canadian Light Source (Saskatoon, Sas-
katchewan, Canada), beamline 08B1-1 at −180 °C. The data were indexed and
integrated using Mosflm46, scaled using Scala47, and merged using Xprep from
Shelx48. The structure was solved by molecular replacement using Phaser49 with
the structure of apo-EcClpP (1YG6)10 as a search model, refined using Phenix50,
and modeled with Coot51. Phenix torsion angle non-crystallographic symmetry
constraints were applied to all identical chains from residues 31 to 205. All 14
copies of ACP1-06 were split into two identical copies, each atom assigned an
occupancy value of 0.5, and the trifluoromethylpyridine portion rotated into the
alternate density. Phenix was then used to refine the occupancy of the ACP1-06
atoms in both conformations50. The final refined structure has excellent geometry
with 98.3% of residues in favored Ramachandran regions.
Apo-NmClpP was dissolved at 5 mg/mL in 25 mM TrisHCl, pH 7.5 and 100
mM KCl. The solution was mixed with and incubated above a well solution
containing 0.2 M potassium thiocyanate and 40% MPD at RT. Diffraction data
from a single apo-NmClpP crystal, flash-frozen in a boiling nitrogen stream, were
collected with 1.23984 Å wavelength X-rays at CLS beamline 08B1-1 at −180 °C.
Diffraction data were indexed and integrated using Mosflm46, scaled using Scala47
and merged using Xprep from Shelx48. The structure was solved by molecular
replacement using Phaser49 with PDB id 5DKP19 as a search model, refined using
Phenix50, and modeled with Coot51. Phenix torsion angle non-crystallographic
symmetry constraints were applied to all identical chains from residues 23 to 199.
The final refined structure has excellent geometry with 98.2% of residues in favored
Ramachandran regions.
To obtain crystals of NmClpP complexed with ADEP-14, NmClpP (10 mg/mL)
was incubated with 1 mM ADEP-14 for 1 h on ice, then mixed at a 1:1 ratio with
well solution containing 0.2 M potassium thiocyanate and 40% MPD on sitting
drop plates. The plates were incubated at 23 °C, and crystals were observed after
two weeks and grew to maximum dimensions within a month. Diffraction data
from flash-frozen crystals were collected at −180 °C with 1.5418 Å X-rays at the
Structural Genomics Consortium-University of Toronto using a Rigaku FR-E
Superbright Rotating Anode generator, then indexed, integrated, and scaled in
HKL200052. The structure of the NmClpP+ADEP-14 complex was determined by
molecular replacement using the apo-NmClpP structure as a search model, and the
solution was initially refined in Phenix with simulated annealing and coordinate
shaking to remove model bias. Clear electron density for ADEP-14 was found in all
28 subunits in the asymmetric unit and the molecules were modeled at occupancy
= 1.0. Subsequent modeling and refinement were performed in Coot and
Phenix50,51 using translation-libration-screw (TLS) parameters with individual
coordinate, B-factor and occupancy refinement. The final refined structure has
excellent geometry with 97.9% of residues in favored Ramachandran regions.
Crystals of the NmClpP E58A and NmClpP E31A+ E58A mutants were
obtained by incubating 10 mg/mL of protein with well solution (1:1 ratio)
containing 0.2 M potassium thiocyanate and 40% MPD using sitting drop plates.
The plates were incubated at 23 °C, and crystals were observed within two weeks
and allowed to grow to maximum dimensions in a month. Crystals of mutant
NmClpP were harvested and diffraction data were collected as above. Diffraction
data collection, processing, structure solution and refinement for both NmClpP
mutants were performed as for the NmClpP+ADEP14 complex. The final refined
structures have excellent geometry with >97.0% of residues in favored
Ramachandran regions. Diffraction data collection and refinement statistics for all
structures are summarized in Table 1.
ClpP barrel volume measurements. ClpP barrel volume measurements were
performed in VMD 1.9.1 using the VolArea extension (Surface and Volume Cal-
culator)53. All analyzed crystal structures of tetradecameric ClpP were first
superimposed on that of apo-NmClpP (5DKP)19 using the align function in
PyMOL54. The active site chamber was defined using the analysis section specified
by the following parameters: width: 52.50, height: 32.86, depth: 50.31, x=−28.66,
y= 31.02, and z=−33.61, and a cavity probe radius of 20 Å. The analysis box for
volume measurements is bounded by residue Val75 (N-terminus of the αC helix) of
each subunit, located at the boundary between the axial pore cavity and the lumen
of ClpP.
Protein expression and purification for NMR. Transformed Codon+ E. coli BL21
(DE3) cells were grown in minimal M9 D2O media supplemented with 15NH4Cl
and d7-glucose as the sole nitrogen and carbon sources, respectively. Cells were
grown at 37 °C and protein overexpression was induced with 0.2 mM IPTG at
OD600= 1.0. Expression was allowed to proceed overnight at 25 °C. Proteins were
purified using Ni-affinity chromatography, followed by removal of the SUMO tag
ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-019-0656-3
12 COMMUNICATIONS BIOLOGY |           (2019) 2:410 | https://doi.org/10.1038/s42003-019-0656-3 | www.nature.com/commsbio
using Ulp1 protease. The cleaved tag and other impurities were removed using
another step of Ni-affinity chromatography. The flow-through from the second Ni-
affinity purification was concentrated using an Amicon Ultra-15 50 K MWCO
(Millipore) concentrator and subjected to gel filtration on a HiLoad 16/60 Superdex
200 column (GE Healthcare) containing 50 mM imidazole, 100 mM KCl, 5 mM
DTT, pH 7.0. Fractions were pooled and MMTS labeling was performed as
described previously22. Protein concentrations were determined in 8M guanidium
chloride using extinction coefficient values obtained from ExPASy’s ProtParam
program. Prior to NMR measurements the samples were buffer-exchanged into
100 mM KCl, 1 mM EDTA, 5 mM MgCl2, and 50 mM imidazole at pH 6.7 pre-
pared in 99.9% D2O.
NMR. All NMR measurements were performed at 18.8 T and 40 °C using a Bruker
AVANCE III HD spectrometer equipped with a cryogenically cooled pulsed-field
gradient triple-resonance probe. 1H-13C correlation spectra were recorded as
HMQC datasets, exploiting a methyl-TROSY effect that is particularly beneficial
for applications to high molecular weight proteins55. Spectra were processed using
the NMRPipe suite of programs56, analyzed using scripts written in-house, and
visualized using Ccpnmr57.
SAXS experiments on NmClpP. SAXS experiments were performed at the
SAXS1 beamline at the Brazilian Synchrotron Light Laboratory (LNLS, CNPEM,
Campinas, São Paulo, Brazil) using a Pilatus 300 K (Dectris) detector. Samples
were collected at the concentration of 1.27 mg/mL in 50 mM TrisHCl (pH 7.5),
containing 200 mM KCl, 25 mM MgCl2 and 10% glycerol. ADEP-04 was used at
the final concentration of 0.7 mM. All samples (in the absence or in the presence
of ADEP-04) were prepared with DMSO at the final concentration of 2.8% (v/v).
Data collection was performed at 20 °C, and every sample was exposed to ten
frames of 10 s and one frame of 300 s. Data processing was done using the
ATSAS 2.7.2 package58. Evaluation of X-ray damage was performed by com-
paring curves from different X-ray exposure times and by analyzing the linearity
of their Guinier regions. Curves were scaled and merged using the DATMERGE
software59. Molecular masses were obtained using the SAXSMoW program60.
Pair distance distribution functions were generated using the GNOM software61.
Restoration of solution ab initio structures was carried out using a simulated-
annealing methodology implemented by the DAMMIN software and a
P72 symmetry (homo-dimer of homo-heptamers) was employed62. Ten models
were generated and compared against each other using the DAMAVER pack-
age43. The DAMs with the lowest normalized spatial discrepancy (NSD) values
were used as reference models. Rendering of DAMs and three-dimensional high-
resolution structures was performed by the UCSF Chimera software63. Deter-
mination of hydrodynamic properties from PDB models was done by the
Hydropro software64.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The atomic coordinates and structure factors for EcClpP+ACP1-06, Apo NmClpP,
NmClpP+ADEP-14, NmClpP E58A, and NmClpP E31A+ E58A, have been deposited
in the Protein Data Bank under the accession codes 6NB1, 6NAQ, 6NAH, 6NAW, and
6NAY, respectively.
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